RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
RXDX
Delisted
RXDX was delisted on the 15th of June, 2023.
219 hedge funds and large institutions have $4.35B invested in Prometheus Biosciences, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 92 increasing their positions, 71 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 221 → 219 (-2)
24% less funds holding in top 10
Funds holding in top 10: 17 → 13 (-4)
Holders
219
Holding in Top 10
13
Calls
$110M
Puts
$29.9M
Top Buyers
| 1 | +$103M | |
| 2 | +$92.4M | |
| 3 | +$46.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$42M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$39.3M |
Top Sellers
| 1 | -$73.1M | |
| 2 | -$46.7M | |
| 3 | -$38.9M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$22.4M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$20.2M |